Fig. 2
From: Downregulation of MAL2 inhibits breast cancer progression through regulating β-catenin/c-Myc axis
MAL2 is upregulated in BC cells. A Western blot analysis of MAL2 expression in BC cell lines and a normal human mammary epithelial cell line (MCF-10 A). B Western blot assay quantifies the knockdown efficiency of MAL2 expression in MDA-MB-231 and MCF-7 cells. C The protein levels of MAL2 in sh-NC and sh-MAL2-treated MDA-MB-231 and MCF-7 cells. All data are represented as mean ± SD. P < 0.05; *P < 0.01;***P < 0.001; ns, not significant